Back
Novavax Stock Predictions
Sponsored
10 POWERFUL Patterns...
Click here to download your copy now
Sell
11
NVAX
Novavax
Last Price:
5.77
Seasonality Move:
16.07%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
How He Bagged One Of The Top Trading Records
Click to see this exclusive sit-down interviewNovavax Stock Forecast
- Over the next 52 weeks, Novavax has on average historically risen by 89.8% based on the past 27 years of stock performance.
- Novavax has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Novavax Stock Undervalued?
The current Novavax [NVAX] share price is $5.78. The Score for NVAX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal. - NVAX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Novavax Stock Go Up Next Year?
- Over the next 52 weeks, Novavax has on average historically risen by 89.8% based on the past 27 years of stock performance.
Novavax Stock Rating
Sell
11
Novavax (NVAX)
is a Sell
Is Novavax overpriced?
- Novavax has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Novavax Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
novavax.com
52-Week Data
52-Week High:
83.54
52-Week Low:
5.68
Prediction Charts
Market Cap:
498.08M
Price in USD:
5.78
Volume:
4.68M
Beta:
1.58
Technical Analysis
SMA50:
9.40
SMA100:
12.89
SMA200:
26.16
52-Wk Change:
-93.1%
Stock Predictions
-
Is Novavax stock public?
Yes, Novavax is a publicly traded company. -
What is the Novavax stock quote today?
The Novavax stock price is 5.78 USD today. -
How to buy Novavax stock online?
You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 6.94 | 7.69 | 7.92 | 6.79 |
| Mar-6 | 7.48 | 7.29 | 7.70 | 7.16 |
| Mar-7 | 7.27 | 6.97 | 7.27 | 6.93 |
| Mar-8 | 6.93 | 6.89 | 6.95 | 6.77 |
| Mar-9 | 6.86 | 6.57 | 6.95 | 6.56 |
| Mar-10 | 6.54 | 6.52 | 6.73 | 6.25 |
| Mar-13 | 6.46 | 6.85 | 7.22 | 6.41 |
| Mar-14 | 6.88 | 6.27 | 7.05 | 6.22 |
| Mar-15 | 6.20 | 5.90 | 6.39 | 5.85 |
| Mar-16 | 5.83 | 5.97 | 6.06 | 5.68 |
| Mar-17 | 5.95 | 5.95 | 6.00 | 5.76 |
| Mar-20 | 5.80 | 5.98 | 6.00 | 5.70 |
| Mar-21 | 6.02 | 6.02 | 6.36 | 5.92 |
| Mar-22 | 6.07 | 5.78 | 6.17 | 5.77 |
Novavax Earnings
Novavax Earnings Report: Per Share Novavax Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novavax Forecast Revenue Growth
Novavax Stock Analysis: Historical quarterly revenues per share for Novavax and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $2.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $3.28 per share.
* Novavax stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.